← Back to all trials
Not Yet Recruiting
NCT05673343
The Prognostic Impact Of The Neutrophil To Lymphocyte Ratio In Patients With Locally Advanced Rectal Cancer
Conditions: the Prognostic Value of Pre-treatment NLR in Patients With Locally Advenced Rectal Cancer and Post-treatment
Sex: All
Ages: 18 Years – 90 Years
Enrollment: 100
Sponsor: Assiut University
Summary
In this study, we aim to investigate the prognostic value of pre-treatment NLR in patients with locally advenced rectal cancer and post-treatment
Eligibility Criteria
Inclusion Criteria:- Patients aged 18-year-old or more 2-Histopathologically proved to be rectal carcinoma.
3- locally advanced stage II and stage III according to AJCC TNM staging 8th edition 4- fit for concurrent chemoradiation therapy (CCRT) with adequate organ function.5- Performance status 0-1 according to ECOG PSExclusion Criteria:1- metastatic disease 2- Younger than 18 year old 3-Any other malignancy 4-There is contraindication for CCRT
Source: ClinicalTrials.gov (NCT05673343). StuddyBuddy aggregates publicly available trial information.
